American Health Intel Rules. Money. Medicine. Decoded daily.
Subscribe
The Ledger · Thursday, November 19, 2026

The Ledger

Rules. Money. Medicine. Decoded daily.
4 stories · 4 min read
Reading as

Inovalon, the Nordic Capital-backed health data and software company, signed a deal to buy DrFirst, the e-prescribing network that reaches more than 2,000 hospitals. The definitive agreement was announced November 11, per a DrFirst press release, and a Healthcare IT Today roundup carried it November 17. We had not covered it. The release says the combined company would serve over 2,000 hospitals and 240,000 prescribing providers, writing 241 million or more prescriptions a year across 270 or more electronic health record integrations. Goldman Sachs advises Inovalon and Nordic Capital, and Citigroup advises DrFirst. No price or financing was disclosed, and the deal needs regulatory approvals with no target closing date. Who it hits: health systems and physician groups that send prescriptions through DrFirst, and rival e-prescribing and medication-history vendors. So what: Inovalon already holds clinical, pharmacy and lab data on 461 million lives per its own release, so the deal pairs that data with the prescribing workflow where it is created. Hospital IT contracts should be read for data-use terms. Confidence: High on the announcement and the stated reach, which are the companies’ own figures; terms are unknown. A note on freshness: the deal is eight days old, and we found no lede-grade item dated inside the last 24 hours.

HCTec, a Nashville managed IT services firm serving more than 250 health systems, now belongs to staffing and IT company CSI Companies. CSI, based in Jacksonville, Florida, announced the acquisition November 12 in a CSI Companies release. HCTec runs outsourced service desks and application management for hospitals, including a KLAS-recognized Clinical Service Desk, and will operate as “HCTec, A CSI Company.” Financial terms were not disclosed. Who it hits: health systems that outsource help desk and electronic record support, and competing managed-services vendors. So what: a staffing firm buying a managed-services firm is one more sign that hospital IT labor is being bought as a contract. Confidence: High on the facts in the release; terms unknown.

Two in-home care benefit managers, Integrated Home Care Services and CareCentrix, agreed to combine, with closing expected in the first half of 2027. The companies announced the agreement November 5 in a CareCentrix release. CareCentrix coordinates care for over 22 million members, and the combined platform would cover home health, personal care, durable medical equipment, home infusion and private duty nursing for Medicare Advantage, Medicaid, commercial and ACA plans. Integrated’s chief executive, Christopher Bradbury, would lead the company, based in Miramar, Florida. No financial terms were disclosed and the deal needs regulatory approval. Who it hits: home health agencies and equipment suppliers contracted to either network, and the plans that outsource home benefits to them. So what: contracted providers face one larger network manager, which matters at the next rate negotiation. Confidence: High on the release’s terms; no terms disclosed. This item is two weeks old and new to us.

Hospitals lost an estimated $132 billion to bad debt and final denials in 2025, up nearly 18% from 2024, per an analysis from revenue cycle firm Kodiak Solutions. Healthcare Dive reported the figures November 9; we read the article, not the Kodiak report. Write-offs equal about 10% of net revenue. Kodiak’s own customer hospitals lost $52 billion, and the $132 billion extrapolates that to all 6,100 U.S. hospitals. The final denial rate stayed near 3%, bad debt near 7% of net revenue, and hospital technology budgets rose 7.6% to $69 billion this year per a Forrester figure the article cites. Who it hits: hospital revenue cycle leaders and the vendors selling them automation. So what: more spending on technology has not shrunk write-offs, which is the pitch the Inovalon and CSI deals sit beside. Confidence: Med, because the total is a vendor’s extrapolation reported by trade press. Older than our window, included as context.

A note on today’s scan: we checked insurer and hospital-operator filings, rating actions, closures, layoffs and deal announcements for the last 48 hours. We could not verify any earnings 8-K from the large insurers or hospital operators dated today, or any health-system rating action with a date. Several wire and trade sites blocked our reader, so the scan is thinner than usual. Surgery Partners has no new development we could confirm after the amended $25 per share HealthSpan Partners deal. Becker’s reported a Labcorp deal for Parkview Health outreach labs, which we could not open or confirm at a primary source, so it appears only as a one-line unverified row below. A frontier check of home care and dental, behavioral and dialysis services found no deal dated November 18 or 19.

THE DEAL SHEET

TargetAcquirer/InvestorVerticalValueSource
DrFirstInovalon (Nordic Capital-backed)E-prescribing and medication managementNot disclosed (announced November 11)DrFirst release
HCTec (Nashville)CSI CompaniesHealthcare IT managed servicesNot disclosed (announced November 12)CSI Companies release
Integrated Home Care ServicesCareCentrix (combination)In-home care benefit managementNot disclosed (announced November 5; close expected first half 2027)CareCentrix release
Parkview Health nonemergent outreach laboratory servicesLabcorpClinical laboratoryNot disclosed; unverified, per a Becker’s headline only, primary release not foundBecker’s Hospital Review

Still pending: Surgery Partners and HealthSpan Partners, $25.00 per share cash, per the Surgery Partners 8-K exhibit.

Get tomorrow's edition in your inbox.

Free. One email a day at 6pm your time, or one summary every Friday. Switch or stop anytime.

Where these stories are tracked
Get the next issue Free, daily